A study utilising the GEO database (GSE13159) revealed that AML patients across various subtypes, including normal karyotype, mixed lineage leukaemia and t(15:17), exhibited significantly elevated RBFOX2 expression in bone marrow samples compared to healthy counterparts. The gene discussed is RBFOX2; the disease is acute myeloid leukemia.